stockrowZymeworks Inc.
ZYME Healthcare Biotechnology
Zymeworks Inc.’s revenue for fiscal 2025 (year ended December 2025) was $106.0 million, up 38.9% from fiscal 2024.
- Revenue
- −90.6%
- EPS
- −2,166.7%
- Free cash flow
- −385.5%
Quarter to June 2026, against a year earlier
Follow ZYME
Alert me
Zymeworks Inc. (ZYME) Operating margin
Zymeworks Inc.'s operating margin over the twelve months to 30 June 2026 was −419.0%, down 331.6 percentage points from fiscal 2025 (−87.3%). Over the past ten years it has ranged from −808.2% (fiscal 2021) to 31.6% (fiscal 2022); the current reading is higher than 73% of that period. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −87.3% | 92.35 |
| FY2024 | −179.7% | 1.93 |
| FY2023 | −181.6% | (213.26) |
| FY2022 | 31.6% | 839.86 |
| FY2021 | −808.2% | (326.93) |
| FY2020 | −481.3% | 30.83 |
| FY2019 | −512.1% | (449.19) |
| FY2018 | −62.9% | (45.55) |
| FY2017 | −17.4% | 326.56 |
| FY2016 | −343.9% | (137.31) |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | −919.0% | 1,037.78 |
| Mar 2026 | −1,956.7% | (201.18) |
| Dec 2025 | −1,755.6% | (1,675.48) |
| Sep 2025 | −80.1% | (78.69) |
| 38 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| AUPH Aurinia Pharmaceuticals Inc compare | 44.8% |
| VCEL Vericel Corporation compare | 8.32% |
| IMNM Immunome, Inc. compare | 0.00% |
| VERA Vera Therapeutics, Inc. compare | 0.00% |
| BHVN Biohaven Ltd. compare | 0.00% |
| COAG Hemab Therapeutics Holdings, Inc. compare | 0.00% |
| SEPN Septerna, Inc. compare | −44.0% |
| LKFT Lakefront Biotherapeutics - Sponsored ADR compare | −90.1% |
| ZYME Zymeworks Inc. | −419.0% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on ZYME
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- The full statement